ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
8.71
-0.10 (-1.14%)
At close: Jul 17, 2026, 4:00 PM EDT
8.68
-0.03 (-0.34%)
After-hours: Jul 17, 2026, 7:06 PM EDT
ADMA Biologics Employees
As of December 31, 2025, ADMA Biologics had 647 total employees, including 640 full-time and 7 part-time employees. The number of employees decreased by 38 or -5.55% compared to the previous year.
Employees
647
Change (1Y)
-38
Growth (1Y)
-5.55%
Revenue / Employee
$788,043
Profits / Employee
$255,570
Market Cap
2.02B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 647 | -38 | -5.55% | 640 | 7 |
| Dec 31, 2024 | 685 | 61 | 9.78% | 677 | 8 |
| Dec 31, 2023 | 624 | 7 | 1.13% | 624 | 0 |
| Dec 31, 2022 | 617 | 90 | 17.08% | 617 | 0 |
| Dec 31, 2021 | 527 | 120 | 29.48% | 527 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Lakefront Biotherapeutics NV | 558 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 307 |
| Syndax Pharmaceuticals | 298 |
| UroGen Pharma | 298 |
| Viridian Therapeutics | 252 |
| Monte Rosa Therapeutics | 187 |
ADMA News
- 4 days ago - Adma Biologics price target lowered to $17 from $20 at Mizuho - TheFly
- 5 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in ADMA BIOLOGICS, INC. Lawsuit - ADMA - GlobeNewsWire
- 13 days ago - $ADMA Fraud Notification: ADMA Biologics Sued for Securities Fraud After Channel Stuffing Claims Spark a 29% Stock Drop – Investors Notified to Contact BFA Law by August 10 - GlobeNewsWire
- 16 days ago - ADMA INVESTOR REMINDER: ADMA Biologics, Inc. Investors Have Until August 10, 2026 To Seek Lead Plaintiff Role - Business Wire
- 19 days ago - ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. - GlobeNewsWire
- 25 days ago - ADMA BIOLOGICS, INC. (ADMA) INVESTOR ALERT Investors With Large Losses in ADMA Biologics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 26 days ago - Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders - Newsfile Corp
- 4 weeks ago - 20 growth stocks priced as value stocks - Market Watch